Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models

Marine Drugs
Emily M HarrisWilliam D Figg

Abstract

Elements of the hypoxia inducible factor (HIF) transcriptional system, a key regulator of the cellular hypoxic response, are up-regulated in a range of cancer cells. HIF is fundamentally involved in tumor angiogenesis, invasion, and energy metabolism. Inhibition of the transcriptional activity of HIF may be of therapeutic benefit to cancer patients. We recently described the identification of two marine pyrroloiminoquinone alkaloids with potent activity in inhibiting the interaction between the oncogenic transcription factor HIF-1α and the coactivator protein p300. Herein, we present further characterization data for these two screening hits: discorhabdin H (1) and discorhabdin L (2), with a specific focus on their anti-angiogenic and anti-tumor effects. We demonstrated that only discorhabdin L (2) possesses excellent anti-angiogenic activity in inhibiting endothelial cell proliferation and tube formation, as well as decreasing microvessel outgrowth in the ex vivo rat aortic ring assay. We further showed that discorhabdin L (2) significantly inhibits in vivo prostate tumor growth in a LNCaP xenograft model. In conclusion, our findings suggest that discorhabdin L (2) represents a promising HIF-1α inhibitor worthy of further drug...Continue Reading

References

Feb 1, 2000·Biochemical and Biophysical Research Communications·E A KrugerW D Figg
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sonja A DamesPeter E Wright
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Steven J FreedmanMichael J Eck
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Aug 31, 2004·Journal of Natural Products·Edith M AntunesMichael T Davies-Coleman
May 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Christina TherapontosNeil Vargesson
May 19, 2010·Marine Drugs·Yasufumi WadaYasuyuki Kita
Jun 22, 2011·Chemical Reviews·Jin-Feng HuShi-Biao Wu
Aug 10, 2016·The Journal of Biological Chemistry·Mun Chiang ChanChristopher J Schofield

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
Assay

Software Mentioned

GraphPad Prism
Adobe Photoshop
Nikon NIS - Elements
GraphPad

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.